Ulcerative colitis
Conditions
Brief summary
The percentage of clinical remission after 12 months of treatment, i.e. the percentage of patients who achieved complete resolution of clinical symptoms of exacerbation of ulcerative colitis (diarrhea and blood in the stool), as well as resolution of endoscopic markers of mucosal inflammation.
Detailed description
1. Assessment of the clinical response rate in the group of patients receiving combination therapy compared to the group of patients receiving biological therapy alone after 14 weeks and 12 months after administration of the first dose of biological drug. 2. Assessment of the percentage of complete clinical remission in the group of patients receiving combined treatment compared to the group of patients receiving biological treatment alone 14 weeks after administration of the first dose of the b
Interventions
DRUGTLEN MEDYCZNY Linde gaz
Sponsors
Medical University Of Gdansk
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The percentage of clinical remission after 12 months of treatment, i.e. the percentage of patients who achieved complete resolution of clinical symptoms of exacerbation of ulcerative colitis (diarrhea and blood in the stool), as well as resolution of endoscopic markers of mucosal inflammation. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Assessment of the clinical response rate in the group of patients receiving combination therapy compared to the group of patients receiving biological therapy alone after 14 weeks and 12 months after administration of the first dose of biological drug. 2. Assessment of the percentage of complete clinical remission in the group of patients receiving combined treatment compared to the group of patients receiving biological treatment alone 14 weeks after administration of the first dose of the b | — |
Countries
Poland
Outcome results
None listed